The ASAM National Practice Guideline Special Populations Webinar - Individuals with Co-occurring Psychiatric Disorders - Fundamentals (0.75 CME)
Recorded On: 06/21/2016
This special populations webinar series follows the National Practice Guideline overview webinar which outlined the recommendations from ASAM's National Practice Guideline for the Use of Medications in the Treatment of Opioid Use Disorders, which is the first guideline to include all medications to treat opioid use disorder.
Co-occurring psychiatric disorders are common among individuals who have opioid use disorder. Studies have demonstrated a higher prevalence of substance use among people with psychiatric disorders relative to the general population. The Individuals with Co-occurring Psychiatric Disorders Webinar will provide an overview of the recommendations and in-depth information on treating individuals with co-occurring psychiatric disorders from ASAM's National Practice Guideline.
This webinar is primarily intended for clinicians involved in evaluating patients and providing authorization for pharmacological treatments at any level.
At the conclusion of the webinar, participants should be able to:
- Recognize epidemiology of opioid use disorder and the treatment gap among patients misusing opioids and heroin.
- Summarize the guideline's treatment recommendations for special populations and discuss how they should be used in practice.
- Identify the fundamental components of an OUD patient assessment and diagnosis for special populations with opioid use disorders.
- Discuss the unique needs and treatment recommendations for individuals with co-occurring psychiatric disorders.
The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASAM designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Addiction Medicine (ABAM) MOC:
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of .75 AMA PRA Category 1 Credits™.
|Adam J. Gordon, MD, MPH, FACP, FASAM, CMRO, Chair, Reviewer||None|
Catherine Friedman, MD, Vice Chair, Reviewer
|Noel Ilogu, MD, MRCP||None|
|Herbert L. Malinoff, MD, FACP, FASAM||None|
|Edwin A. Salsitz, MD, FASAM, Reviewer||None|
|John C. Tanner, DO, FASAM, CCFC, MRO||
Reckitt-Benckiser: Honorarium, Speaker
Orexo: Honorarium, Speaker
BDSI: Honorarium, Speaker & Consultant
|Adam J. Gordon, MD, MPH, FACP, FASAM, CMRO||None|
|Margaret A. E. Jarvis, MD, FASAM||
Geisinger Health System: Salary, Medical Director
US Preventive Health: Dividend, Stockholder
Hoffspiegel and Associates: Fees, Expert Witness
Up-to-Date: Royalties, Author
|Robert J. Roose, MD, MPH||Health New England, Inc.: Honorarium, Behavioral Health Advisory Committee, Associate Medical Director|
|Marc Fishman, MD, DFASAM||
Maryland Treatment Centers: Employment, Ownership Interest includes stock, stock options, patent or other intellectual property
US World Meds: Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received
|Aaron D. Fox, MD, MS||None|
|Brian Hurley, MD, MBA, DFASAM||None|
|Yngvild Olsen, MD, MPH, FASAM||None|
|Tricia Wright, MD, MS, FACOG, FASAM||None|
Dr. Brian Hurley, MD, MBA, DFASAM
Director of Addiction Medicine, Los Angeles County Department of Health Services
Dr. Brian Hurley is an addiction psychiatrist and Medical Director for Co-Occurring Disorder Services for the Los Angeles County Department of Mental Health (LACDMH), supporting the identification and management of co-occurring substance use among patients with mental illness served by LACDMH. He is an assistant professor of Addiction Medicine at UCLA.
Brian serves as the Treasurer and is a Distinguished Fellow of the American Society of Addiction Medicine. Brian joined ASAM in 2002 as a first year medical student, and has served on the ASAM Board of Directors in various capacities since 2003. Brian previously served as chair of ASAM’s Membership Committee and Physicians-in-Training Committee and is formerly ASAM’s alternate delegate to the American Medical Association. Brian additionally served on the EVP/CEO search committee in 2010 that led to Penny Mill’s selection as ASAM’s current EVP/CEO. He has additional served in various roles for the Massachusetts Society of Addiction Medicine, New York Society of Addiction Medicine, and California Society of Addiction Medicine.
Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed residency training at the Massachusetts General Hospital and McLean Hospital, where he was Chief Resident in Addiction Psychiatry and addiction psychiatry fellowship training at Bellevue Hospital and the New York Veterans Administration. Brian is a graduate of the Keck School of Medicine and Marshall School of Business of the University of Southern California. He was a 2012 American College of Psychiatrists Laughlin fellow, a 2010-2013 American Psychiatric Association (APA) Public Psychiatry Fellow, and a 2015-2017 Group for Advancement of Psychiatry Fellow. Brian has previously served on the Board of Trustees of the APA.